newsfilter
← Latest News
Business Wire·

Cortexyme to Present at the BofA Securities 2021 Healthcare Conference on May 11, 2021

Cortexyme, Inc. (NASDAQ:CRTX), a company advancing a pivotal trial in Alzheimer's disease with topline data expected in the fourth quarter of 2021 and a growing pipeline of therapeutics for degenerative diseases, today announced Chris Lowe, the company'